Clinical Trials Sponsored by IRCM U1194 INSERM, Tumor Microenvironment and Resistance to Treatment Lab
Total 1 results
-
University Hospital, MontpellierIRCM U1194 INSERM, Tumor Microenvironment and Resistance to Treatment Lab; IRCM...Recruiting
Sponsors and Collaborators
- Hopeful Aging
- Sahar Salehi
- The People's Hospital of Guangxi Zhang Autonomous Region
- Only For Children Pharmaceuticals
- Kerstyn C. Zalesin, M.D.
- Kuwait University
- Xiao-Ming Mao
- Van Boven, Robert W., M.D.
- Biorobotic Institute Scuola Superiore sant'Anna Pisa
- Genuv Inc.
- Klinikum Bad Woerishofen
- Jia Liu
- Marcus Vinícius Guimarães de Lacerda
- Hoersholm Hospital
- Liming Cheng
- Egyptian Russian University
- Friedrich Miescher Institute for Biomedical Research (FMI)
- Pancreatic Cancer UK
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Royal Hobart Hospital Research Foundation (funding source)
- View Full List
Medical Conditions
- Smith-Lemli-Opitz Syndrome
- Autologous Haematopoietic Stem Cell Transplant
- Gait Variability; Elders; Fall; Re-education
- Stage II Vulvar Cancer
- High Perinatal Mortality
- EHMT1
- Advanced Gastric Cancer With Serosal Invasion
- Enlarged Uterus
- Raynaud Secondary to Other Autoimmune Disease
- Role of Vitamin D in IVF for Better Outcome
- Urinary Tract Carcinoma
- Global Health
- Pancytopenia Due to Chemotherapy
- Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
- Secondary Hypertension to Endocrine Disorders
- Airway Obstruction
- Stereotype-threat
- Pulmonary Invasive Aspergillosis
- Caffeine Dosage
- Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
- View Full List
Drug Interventions
- Ibudilast
- Naltrexone and bupropion SR
- APD334
- Nystatin
- P276-00
- Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 50 U
- Olopatadine hydrochloride ophthalmic solution 0.7%)
- IBI318
- Iohexol Inj 300 MG/ML
- ACP-204
- Ustekinumab
- LX4211 800 mg
- Omalizumab Injection
- CAZ/AVI plus Aztreonam
- Vehicle Foam with UVA and UVB and visible light irradiation
- RDEA3170 12 mg
- Androgen-deprivation Therapy (ADT)
- MC-1101
- High-dose loop diuretics
- Jatenzo
- View Full List
CROs by country
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Canada
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Malawi
- Contract Research Organizations in Malta
- Contract Research Organizations in Moldova
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Panama
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Portugal
- Contract Research Organizations in Singapore
- Contract Research Organizations in Suriname
- Contract Research Organizations in Togo
- CRO list by country